The antimitotic effects of Ukrain(TM), a Chelidonium majus alkaloid derivative, are reversible in vitro

Cancer Letters

Volumn 150, Issue 1, 2000, Pages 85-92

  Panzer, Annie ^a   Joubert, Anna M ^a   Bianchi, Pepita C ^b   Seegers, Johanna C ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Cancer; Reversibility; Selective toxicity; Ukrain

Indexed keywords

CHELIDONIUM EXTRACT; UKRAIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL SURVIVAL; CLONOGENIC ASSAY; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; METAPHASE; NONHUMAN; PLOIDY; PRIORITY JOURNAL;

ALKALOIDS; ANIMALS; ANTINEOPLASTIC AGENTS; BERBERINE ALKALOIDS; CELL CYCLE; CERCOPITHECUS AETHIOPS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HELA CELLS; HISTOCYTOCHEMISTRY; HUMANS; MITOSIS; PAPAVER; PHENANTHRIDINES; PLANTS, MEDICINAL; TIME FACTORS; TUMOR CELLS, CULTURED; VERO CELLS;

ANIMALIA; CHELIDONIUM; CHELIDONIUM MAJUS;

EID: 0034051409     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00375-4     Document Type: Article

References (16)

1. Danysz A., Kokoschinegg M., Hamler F. Clinical studies of Ukrain in healthy volunteers (phase 1). Drugs Exp. Clin. Res. 18:1992;39-43.
2. Uglyanica K.N., Fomin K.A., Nefyodov L.I., Nowicky J.W., Brzosko W.J., Jankowski A. Influence of Ukrain on patients with surgically treated breast cancer. Part I. Clinical and laboratory parameters. Drugs Exp. Clin. Res. 22:1996;135-138.
3. Pengsaa P., Wongpratoom W., Vatanasapt V., Udomthavornsuk B., Mairieng E., Tangvorapongchai V., Pesi M., Krusan S., Boonvisoot V., Nowicky J.W. The effects of thiophosphoric acid (Ukrain) on cervical cancer, stage IB bulky. Drugs Exp. Clin. Res. 18:1992;69-72.
4. Susak Y.M., Zemskov V.S., Yaremchuk O.Y., Kravchenko O.B., Yatsyk I.M., Korsh O.B. Comparison of chemotherapy and X-ray therapy with Ukrain monotherapy for colorectal cancer. Drugs Exp. Clin. Res. 22:1996;43-50.
5. Liepins A., Nowicky J.W. Ukrain is selectively cytostatic and/or cytotoxic to human tumor and HIV-infected cells, but not to normal human cells. Adam D., Buchner T., Rubinstein E. Recent Advances in Chemotherapy. 1992;2660-2661 Futuramed, Munich.
6. A. Liepins, J.W. Nowicky, Selective induction of programmed cell death (apoptosis) in malignant cells by the alkaloid derivative Ukrain (NSC-613570). 11th future trends in chemotherapy, Interdisciplinary World Congress on Antimicrobial and Anticancer Drugs, 1994, Abstract 93.
7. Hohenwarter O., Strutzenberger K., Katinger H., Liepins A., Nowicky J.W. Selective inhibition of in vitro cell growth by the anti-tumour drug Ukrain. Drugs Exp. Clin. Res. 18:1992;1-4.
8. Voltchek I., Kamyshentsev M., Lavinsky Y., Nowicky J., Medvedev Y., Litvinchuk L. Comparative study of the cytostatic effects of Oliphen and Ukrain. J. Chemother. 8:1996;144-146.
9. Nowicky J.W., Hiesmayr W., Nowicky W., Liepins A. Influence of Ukrain on DNA, RNA and protein synthesis in malignant cells. Drugs Exp. Clin. Res. 22:1996;9-19.
10. Nowicky J.W. Ukrain. Drugs Future. 18:1993;1011-1015.
11. Sotomayor E.M., Rao K., Lopez D.M., Liepins A. Enhancement of macrophage tumouricidal activity by the alkaloid derivative Ukrain. In vitro and in vivo studies. Drugs Exp. Clin. Res. 18:1992;5-11.
12. Sokoloff B. The oncostatic and oncolytic factors present in certain plants. Oncology. 22:1968;49-60.
13. Simanek V. The Alkaloids. 1985;Academic Press, New York. pp. 185-240.
14. Seegers J.C., Bohmer L.H., Kruger M.C., Lottering M.L., de Kock M. A comparative study of ochratoxin A-induced apoptosis in hamster kidney and HeLa cells. Toxicol. Appl. Pharmacol. 129:1994;1-11.
15. Waldman T., Zhang Y., Dillehay L., Yu J., Kinzler K., Vogelstein B., Williams J. Cell-cycle arrest versus cell death in cancer therapy. Nat. Med. 3:1997;1034-1036.
16. Scholz C., Hansel R., Hille C. Quantitative Dünnschichtchromatographie der Chelidonium-Hauptalkaloide. Pharmazeutische Zeitung. 121:1976;1571-1574.